These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9364996)

  • 1. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
    Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
    Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
    Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
    Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
    Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
    J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.
    Luksch A; Polak K; Beier C; Polska E; Wolzt M; Dorner GT; Eichler HG; Schmetterer L
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3080-4. PubMed ID: 10967067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen.
    Jilma B; Pernerstorfer T; Dirnberger E; Stohlawetz P; Schmetterer L; Singer EA; Grasseli U; Eichler HG; Kapiotis S
    J Lab Clin Med; 1998 Feb; 131(2):151-6. PubMed ID: 9488498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
    Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
    Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
    Barbato E; Piscione F; Bartunek J; Galasso G; Cirillo P; De Luca G; Iaccarino G; De Bruyne B; Chiariello M; Wijns W
    Circulation; 2005 Jan; 111(3):288-94. PubMed ID: 15642763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of inotropic and chronotropic effects of NG-monomethyl-L-arginine.
    Brillante DG; O'Sullivan AJ; Johnstone MT; Howes LG
    Eur J Clin Invest; 2009 Apr; 39(4):273-9. PubMed ID: 19292882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans.
    Ardilouze JL; Fielding BA; Currie JM; Frayn KN; Karpe F
    Circulation; 2004 Jan; 109(1):47-52. PubMed ID: 14662716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy].
    Shinke T; Takaoka H; Takeuchi M; Hata K; Kawai H; Okubo H; Kijima Y; Murata T; Yokoyama M
    J Cardiol; 2001 Feb; 37(2):119-20. PubMed ID: 11255696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and cardiac parasympathetic control in human heart failure.
    Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
    Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors.
    Marín J; Balfagón G
    Br J Pharmacol; 1998 Jun; 124(3):473-8. PubMed ID: 9647470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous nitric oxide in the control of esophageal motility in humans.
    Konturek JW; Thor P; Lukaszyk A; Gabryelewicz A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Jun; 48(2):201-9. PubMed ID: 9223025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.